Truvian has built the world’s first 3 modality point-of-care blood testing device, disrupting the archaic world of centralized lab testing. This desktop, printer-sized device allows clinicians to run a test on 30 analytes in under 40 minutes from a single, pediatric sized vial of blood in a non-lab environment. Truvian is advancing the shift toward value-based care and empowering patients and healthcare providers alike to make better, data-driven decisions about their health.

Our other investment companies